- Pathogenesis and Therapeutic Strategies Related to Non-Alcoholic Fatty Liver Disease
Tieshan Teng et al, 2022, International Journal of Molecular Sciences CrossRef - Emerging Role of GLP-1 Agonists in Obesity: A Comprehensive Review of Randomised Controlled Trials
Mihaela-Simona Popoviciu et al, 2023, International Journal of Molecular Sciences CrossRef - GLP1-receptor-agonisták a 2-es típusú diabetes vércukorcsökkentő kezelésében
Gábor Winkler, 2022, Orvosi Hetilap CrossRef - Microbiota-gut-brain axis: relationships among the vagus nerve, gut microbiota, obesity, and diabetes
Susanna Longo et al, 2023, Acta Diabetologica CrossRef - Real-world evaluation of weekly subcutaneous treatment with semaglutide in a cohort of Italian diabetic patients
P. Marzullo et al, 2022, Journal of Endocrinological Investigation CrossRef - Effect of Semaglutide on Subclinical Atherosclerosis and Cardiometabolic Compensation: A Real-World Study in Patients with Type 2 Diabetes
Angelo Maria Patti et al, 2023, Biomedicines CrossRef - The SGLT-2 Inhibitors in Personalized Therapy of Diabetes Mellitus Patients
Mariana Tilinca et al, 2021, Journal of Personalized Medicine CrossRef